编号：20190925 证券代码：300020 证券简称：银江股份 银江股份有限公司投资者关系活动记录表 | --- | --- | |-----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...

证券代码：300020 证券简称：银江股份 银江股份有限公司投资者关系活动记录表 编号：20171206 | --- | --- | --- | |-----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...

编号：20190606 证券代码：300020 证券简称：银江股份 银江股份有限公司投资者关系活动记录表 | --- | --- | |-----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 投资者关系活动 类别 | 特定对象调研 | | ...

编号：20180511 证券代码：300020 证券简称：银江股份 银江股份有限公司投资者关系活动记录表 | --- | --- | |---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | 投资者关系活动 类别 | 特定对象调研 ...

Financial Performance - In 2020, the company achieved an operating income of CNY 2,138.18 million, a year-on-year increase of 2.82% [2] - The net profit attributable to shareholders was CNY 157.70 million, up 5.11% year-on-year [3] - In Q1 2021, the operating income was CNY 507.73 million, a decrease of 3.40% year-on-year, while the net profit attributable to shareholders was CNY 57.72 million, an increase of 3.77% [3] Business Segmentation - In 2020, the revenue breakdown was as follows: Smart Transportation 47.23%, Smart Healthcare 15.62%, Smart City 36.09%, and other services [3] - The company has transformed into a city brain operation service provider, improving revenue structure and achieving significant results in various fields [3] Technological Innovations - As of the end of 2020, the company held 218 patents (including 164 invention patents), 64 registered trademarks, and 91 qualification certificates [4] - The company is focusing on the development of V2X terminal devices, with the HERO traffic signal machine 1.0 version currently in small batch production and testing [5] Future Plans - The company aims to enhance its urban brain operation services by leveraging IoT, cloud computing, big data, and AI technologies [6] - Plans to expand the deployment of town and street brains in various cities, including Hangzhou and Chengdu, are underway [4] Market Strategy - The company is committed to building a complete market marketing network across the country, focusing on integrated business in smart transportation and traffic governance [5] - The strategy includes a three-in-one corporate development strategy and operational tactics to create an open ecosystem across the entire industry chain [5] Industry Trends - The company recognizes the importance of top-level design and data integration in the development of new-type smart cities, emphasizing the need to break down data silos and enhance urban-rural coordination [7] - The year 2021 marks the beginning of China's 14th Five-Year Plan, with the company focusing on consolidating existing businesses while exploring new fields and products [7]

证券代码：300020 证券简称：银江股份 编号：20210507 1 银江股份有限公司投资者关系活动记录表 | --- | --- | --- | |-------------------------|--------------------------------------------|---------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | □特定对象调研 | □分析师会议 | | 类别 | □媒体采访 | ■业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | □其他 | （请文字说明其他活动内容） | | 参与单位名称及 人员姓名 | | 参加公司2020年度网上业绩说明会的投资者 | | 时间 | 2021年5月7日，15:00-17:00 | | | 地点 | 全景网"投资者关系互动平台" | | | 上市公司接待人 | 董事长 陈才君先生； | 董 ...

证券代码：300020 证券简称：银江技术 编号：20220125 银江技术股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|----------------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | ■特定对象调研 | □分析师会议 | | 类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | □其他（请文字说明其他活动内容） | | | 参与单位名称及 | | 财通证券、国家风险投资基金、来源发展、今越科技、米游科 | | 人员姓名 | 技、南鼎资产及个人投资者等共13人 | | | 时间 | 2022年1月25日 | | | 地点 | | 浙江省杭州市富阳区九龙大道中国智谷富春园区A1幢会议室 | | 上市公司接待人 | 董事、副总经理、董事会秘书 | 花少富先生； | | 员姓名 | 证券事务代表 | 吴孟立先生 | | | 1 ...

证券代码：300020 证券简称：银江技术 银江技术股份有限公司投资者关系活动记录表 编号：20220507 | --- | --- | --- | |-----------------------|------------------------------------------------------|---------------------------------------------------------| | | | | | 投资者关系活动 | □特定对象调研 | □分析师会议 | | 类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | | □现场参观 | | | | ■其他（电话会议） | | | 参与单位名称及 | | 海通证券、中邮保险、建信信托、进门财经、名禹资产、卓财 | | 人员姓名 | 投资、明河投资、中域投资等共13人 | | | 时间 | 2022年5月7日 | | | 地点 | 电话会议 | | | 上市公司接待人 员姓名 | 董事、副总经理、董事会秘书 证券事务代表 吴孟立先生 | 花少富先生； | | | | | | | | 20 ...

证券代码：300020 证券简称：银江技术 编号：20220513 银江技术股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|--------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系 | ■特定对象调研 | □分析师会议 | | 活动类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | | | ■现场参观 □其他（请文字说明其他活动内容） | | 参与单位名称 | | 财通证券、国泰君安、中泰证券、证券日报、同花顺、大象咨 | | | | | | 及人员姓名 | | 询、俊皓集团、九禄投资及个人投资者等共21人 | | 时间 | 2022年5月13日，14:30-1 ...

Financial Performance - The company's revenue for Q3 2022 was ¥351,755,160.97, a decrease of 11.98% compared to the same period last year[3] - The net profit attributable to shareholders was ¥9,948,745.95, down 16.38% year-on-year[3] - The net profit excluding non-recurring gains and losses was ¥8,576,221.49, an increase of 18.82% compared to the same period last year[3] - Basic earnings per share were ¥0.01, a decrease of 50.00% compared to the same period last year[3] - Total operating revenue for Q3 2022 was CNY 1,280,533,526.90, a decrease of 14.06% compared to CNY 1,489,652,416.08 in the same period last year[17] - Net profit for Q3 2022 was CNY 77,521,091.30, a decline of 25.4% compared to CNY 103,902,551.36 in Q3 2021[18] - The total comprehensive income for the third quarter was CNY 78,904,538.14, compared to CNY 5,477,979.36 in the previous year, indicating a significant increase[19] - The company reported a basic and diluted earnings per share of CNY 0.12, down from CNY 0.16 in the previous year[19] Cash Flow and Assets - The operating cash flow net amount for the year-to-date was ¥79,480,490.75, showing a significant increase of 118.49%[3] - As of September 30, 2022, the company's cash and cash equivalents amount to RMB 191,113,534.07, a decrease from RMB 425,997,510.12 at the beginning of the year[14] - The company's cash and cash equivalents were not explicitly stated but can be inferred from the decrease in current assets, which totaled CNY 4,289,762,779.37, down from CNY 4,488,279,292.89[16] - The total cash and cash equivalents at the end of the period were CNY 129,985,530.82, a decrease from CNY 287,360,389.44 at the end of the previous year[22] - The cash inflow from operating activities totaled CNY 1,523,835,311.87, while cash outflow was CNY 1,444,354,821.12, leading to a net cash inflow[22] - The total cash inflow from financing activities was CNY 1,438,658,878.60, while the cash outflow was CNY 1,680,022,786.34, resulting in a net cash flow of CNY -241,363,907.74[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,471,116,615.88, a decrease of 1.79% from the end of the previous year[3] - The company's total assets as of Q3 2022 amounted to CNY 6,471,116,615.88, a decrease from CNY 6,589,119,675.96 at the end of the previous quarter[16] - Total liabilities decreased to CNY 2,931,027,863.29 in Q3 2022 from CNY 3,109,008,989.34 in the previous quarter[16] - The total equity attributable to shareholders of the parent company increased to CNY 3,513,237,740.30 from CNY 3,450,812,699.29[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 50,464[10] - The largest shareholder, Yinjian Technology Group Co., Ltd., holds 12.49% of shares, amounting to 81,883,007 shares, with 81,500,000 shares pledged[10] - The top ten shareholders include both institutional and individual investors, with significant holdings by Yinjian Technology Group and other individuals[10] - The total number of shares held by the top ten unrestricted shareholders is 81,883,007 shares, primarily held by Yinjian Technology Group and other individual shareholders[10] - The company has engaged in margin trading, with several shareholders participating through credit accounts[10] Research and Development - The company reported a significant increase in research and development expenditures, indicating a focus on innovation[8] - Research and development expenses for Q3 2022 were CNY 43,635,098.64, slightly down from CNY 44,360,724.07 in the same period last year[18] - The company experienced a significant increase in development expenditures, which rose to CNY 61,044,859.25 from CNY 27,020,372.27 in the previous quarter[16] Investment and Financing Activities - The company plans to raise up to RMB 1 billion through a private placement of A-shares, with net proceeds intended for the "Urban Brain" solution development and implementation project, a smart hospital project, and to supplement working capital[12] - The company experienced a reduction in investment income due to the disposal of equity in an associate during the reporting period[8] - Investment activities resulted in a net cash outflow of CNY -62,373,906.84, a decrease from a net inflow of CNY 235,947,087.28 in the previous year[22] Other Information - The company has implemented a stock option incentive plan, with adjustments made to the plan's exercise price and the number of options granted[11] - The company is currently in the review and inquiry stage with the Shenzhen Stock Exchange regarding its private placement application[12] - The company has not disclosed any changes in restricted shares during the reporting period[11] - The company did not conduct any audited review of the third-quarter report[23]